Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study

European Urology Supplements ◽

10.1016/s1569-9056(19)34626-3 ◽

2019 ◽

Vol 18 (11) ◽

pp. e3464

Author(s):

I. Rivero Belenchón ◽

C. Muñoz Calahorro ◽

I. Osmán García ◽

P. Beardo Villar ◽

C.B. Congregado Ruíz ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Abiraterone Acetate ◽

Prognosis of metastatic castration‐resistant prostate cancer in the era of the second‐generation androgen receptor‐targeted agents: A retrospective multicenter study

International Journal of Urology ◽

10.1111/iju.14392 ◽

2020 ◽

Author(s):

Hiromichi Iwamura ◽

Shingo Hatakeyama ◽

Shintaro Narita ◽

Yoichi Arai ◽

Tomonori Habuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Multicenter Study ◽

Second Generation ◽

Targeted Agents ◽

Castration Resistant ◽

Retrospective Multicenter Study

Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-021-05298-z ◽

2021 ◽

Author(s):

Cem Onal ◽

Gokhan Ozyigit ◽

Ezgi Oymak ◽

Ozan Cem Guler ◽

Burak Tilki ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Stereotactic Radiotherapy ◽

Castration Resistant ◽

Psma Pet ◽

Pet Ct

Switching from prednisone to dexamethasone in metastatic castration resistant prostate cancer treated with abiraterone acetate in a multicenter study

European Urology Open Science ◽

10.1016/s2666-1683(20)33180-3 ◽

2020 ◽

Vol 19 ◽

pp. e897-e898

Author(s):

I. Rivero Belenchón ◽

C. Muñoz Calahorro ◽

I. Osmán García ◽

P. Beardo Villar ◽

C.B. Congregado Ruíz ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Abiraterone Acetate ◽

Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy: PREMIERE-SOGUG Trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps5073 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS5073-TPS5073

Author(s):

Enrique Grande ◽

Enrique Gonzalez-Billalabeitia ◽

Ignacio Duran ◽

Carmen Santander ◽

Enrique Gallardo Diaz ◽

...

Keyword(s):

Prostate Cancer ◽

Blood Sample ◽

Phase Ii ◽

Multicenter Study ◽

Predictive Value ◽

Fusion Gene ◽

Phase 2 multicenter study of enzalutamide in metastatic castration resistant prostate cancer to identify mechanisms driving resistance

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-4616 ◽

2021 ◽

pp. clincanres.4616.2020

Author(s):

Rana R. McKay ◽

Lucia Kwak ◽

Jett Crowdis ◽

Jamie M. Sperger ◽

Shuang G Zhao ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Phase 2 ◽

Faculty Opinions recommendation of Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718357923.793494159 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Multicenter Study ◽

Abiraterone Acetate ◽

Prednisone Therapy ◽

P115 A phase 2 multicenter study of the investigational single agent orteronel (ortl, TAK-700) in nonmetastatic castration-resistant prostate cancer (nmCRPC) and rising prostate-specific antigen (PSA)

European Urology Supplements ◽

10.1016/s1569-9056(13)60481-9 ◽

2012 ◽

Vol 11 (5) ◽

pp. 230-231 ◽

Cited By ~ 1

Author(s):

M. Hussain ◽

P.G. Corn ◽

D. Michaelson ◽

H.J. Hammers ◽

J.J. Alumkal ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Multicenter Study ◽

Single Agent ◽

Specific Antigen ◽

Phase 2 ◽

Real-world outcomes of enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: A retrospective, multicenter study in Korea

European Urology Supplements ◽

10.1016/s1569-9056(16)30444-4 ◽

2016 ◽

Vol 15 (13) ◽

pp. e1654 ◽

Cited By ~ 1

Author(s):

M. Kang ◽

J.K. Kim ◽

B.S. Tae ◽

J.H. Ku ◽

C. Kwak ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Real World ◽

Castration Resistant ◽

Retrospective Multicenter Study

A prospective multicenter study of intermittent chemotherapy with docetaxel and prednisolone for castration-resistant prostate cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyw021 ◽

2016 ◽

Vol 46 (6) ◽

pp. 547-553 ◽

Cited By ~ 3

Author(s):

Shintaro Narita ◽

Takuya Koie ◽

Shigeyuki Yamada ◽

Kazuhiko Orikasa ◽

Shigeki Matsuo ◽

...

Keyword(s):

Prostate Cancer ◽

Multicenter Study ◽

Prospective Multicenter Study ◽

Castration Resistant ◽

Intermittent Chemotherapy